131 related articles for article (PubMed ID: 20799047)
1. Erythrocyte-protective effect of sarpogrelate hydrochloride (Anplag ®), a selective 5-HT2 receptor antagonist: an in vitro study.
Nakamura K; Kawahito K
J Artif Organs; 2010 Sep; 13(3):178-81. PubMed ID: 20799047
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetic analysis of antiplatelet effect of sarpogrelate hydrochloride and its application to drug dosage regimen--modeling based on reversible inhibition of 5-HT2 serotonergic receptor in the platelet membrane by sarpogrelate hydrochloride and its metabolite].
Shimizu T; Yamada Y; Tashita A; Yamamoto K; Kotaki H; Sawada Y; Iga T
Yakugaku Zasshi; 1999 Nov; 119(11):850-60. PubMed ID: 10590712
[TBL] [Abstract][Full Text] [Related]
3. The 5-hydroxytryptamine2A receptor antagonist sarpogrelate hydrochloride inhibits acute platelet aggregation in injured endothelium.
Houkin K; Nakayama N; Nonaka T; Koyanagi I
J Int Med Res; 2006; 34(1):65-72. PubMed ID: 16604825
[TBL] [Abstract][Full Text] [Related]
4. Effects of sarpogrelate hydrochloride on platelet aggregation, and its relation to the release of serotonin and P-selectin.
Nakamura K; Kariyazono H; Moriyama Y; Toyohira H; Kubo H; Yotsumoto G; Taira A; Yamada K
Blood Coagul Fibrinolysis; 1999 Dec; 10(8):513-9. PubMed ID: 10636463
[TBL] [Abstract][Full Text] [Related]
5. Electroencephalographical effects of sarpogrelate hydrochloride versus ticlopidine hydrochloride in elderly patients with peripheral atherosclerosis.
Iwakuma H
J Int Med Res; 2004; 32(3):274-83. PubMed ID: 15174221
[TBL] [Abstract][Full Text] [Related]
6. Effects of sarpogrelate hydrochloride on adenosine diphosphate- or collagen-induced platelet responses in arteriosclerosis obliterans.
Nakamura K; Kariyazono H; Masuda H; Sakata R; Yamada K
Blood Coagul Fibrinolysis; 2001 Jul; 12(5):391-7. PubMed ID: 11505083
[TBL] [Abstract][Full Text] [Related]
7. A new method for assessment of an anti-5HT(2A) agent, sarpogrelate hydrochloride, on platelet aggregation.
Satoh K; Yatomi Y; Ozaki Y
J Thromb Haemost; 2006 Feb; 4(2):479-81. PubMed ID: 16420586
[No Abstract] [Full Text] [Related]
8. Sarpogrelate hydrochloride, a 5-HT2A receptor antagonist, attenuates neurogenic pain induced by nucleus pulposus in rats.
Hashizume H; Kawakami M; Yoshida M; Okada M; Enyo Y; Inomata Y
Spine (Phila Pa 1976); 2007 Feb; 32(3):315-20. PubMed ID: 17268262
[TBL] [Abstract][Full Text] [Related]
9. The 5-HT2 receptor antagonist sarpogrelate reduces urinary and plasma levels of thromboxane A2 and urinary albumin excretion in non-insulin-dependent diabetes mellitus patients.
Ogawa S; Takeuchi K; Sugimura K; Sato C; Fukuda M; Lee R; Ito S; Sato T
Clin Exp Pharmacol Physiol; 1999; 26(5-6):461-4. PubMed ID: 10386239
[TBL] [Abstract][Full Text] [Related]
10. Sarpogrelate hydrochloride reduced intimal hyperplasia in experimental rabbit vein graft.
Kodama A; Komori K; Hattori K; Yamanouchi D; Kajikuri J; Itoh T
J Vasc Surg; 2009 May; 49(5):1272-81. PubMed ID: 19233592
[TBL] [Abstract][Full Text] [Related]
11. Sarpogrelate, a specific 5HT2-receptor antagonist, improves the coronary microcirculation in coronary artery disease.
Satomura K; Takase B; Hamabe A; Ashida K; Hosaka H; Ohsuzu F; Kurita A
Clin Cardiol; 2002 Jan; 25(1):28-32. PubMed ID: 11808836
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of serotonin-induced vascular smooth muscle cell proliferation by sarpogrelate.
Sharma SK; Zahradka P; Chapman D; Kumamoto H; Takeda N; Dhalla NS
J Pharmacol Exp Ther; 1999 Sep; 290(3):1475-81. PubMed ID: 10454527
[TBL] [Abstract][Full Text] [Related]
13. Sarpogrelate hydrochloride, a selective 5-hydroxytryptamine(2A) antagonist, augments autologous bone marrow mononuclear cell implantation-induced improvement in endothelium-dependent vasodilation in patients with critical limb ischemia.
Higashi Y; Miyazaki M; Goto C; Sanada H; Sueda T; Chayama K
J Cardiovasc Pharmacol; 2010 Jan; 55(1):56-61. PubMed ID: 19834330
[TBL] [Abstract][Full Text] [Related]
14. Persistent insulin-sensitizing effects of sarpogrelate hydrochloride, a serotonin 2A receptor antagonist, in patients with peripheral arterial disease.
Kokubu N; Tsuchihashi K; Yuda S; Hase M; Eguchi M; Wakabayashi T; Hashimoto A; Nakata T; Miura T; Ura N; Nagao K; Tsuzuki M; Wakabayashi C; Shimamoto K
Circ J; 2006 Nov; 70(11):1451-6. PubMed ID: 17062970
[TBL] [Abstract][Full Text] [Related]
15. Effects of sarpogrelate on blood viscosity.
Yum KS; Kang SG; Lee JW; Cho YI
Microvasc Res; 2023 Jan; 145():104439. PubMed ID: 36126755
[TBL] [Abstract][Full Text] [Related]
16. Effects of sarpogrelate, a novel 5-HT2 antagonist, on 5-HT-induced endothelium-dependent relaxations in porcine coronary artery.
Rashid M; Nakazawa M; Nagatomo T
Jpn J Pharmacol; 2002 Aug; 89(4):405-12. PubMed ID: 12233819
[TBL] [Abstract][Full Text] [Related]
17. Peripheral 5-HT₁D and 5-HT₇ serotonergic receptors modulate sympathetic neurotransmission in chronic sarpogrelate treated rats.
García-Pedraza JÁ; García M; Martín ML; Gómez-Escudero J; Rodríguez-Barbero A; Román LS; Morán A
Eur J Pharmacol; 2013 Aug; 714(1-3):65-73. PubMed ID: 23769743
[TBL] [Abstract][Full Text] [Related]
18. Effect of sarpogrelate hydrochloride, a 5-hydroxytryptamine2 receptor antagonist, on allograft arteriosclerosis after aortic transplantation in rats.
Watada S; Harada H; Matsubara K; Obara H; Matsumoto K; Ando N; Kitagawa Y
Transpl Immunol; 2013 Dec; 29(1-4):162-6. PubMed ID: 23851153
[TBL] [Abstract][Full Text] [Related]
19. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
[TBL] [Abstract][Full Text] [Related]
20. Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy.
Kobayashi S; Satoh M; Namikoshi T; Haruna Y; Fujimoto S; Arakawa S; Komai N; Tomita N; Sasaki T; Kashihara N
Clin Exp Nephrol; 2008 Apr; 12(2):119-125. PubMed ID: 18175064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
